Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatients

M. M. Kincaid, P. D. Harvey*, M. Parrella, L. White, K. M. Putnam, P. Powchik, M. Davidson, R. C. Mohs

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

This study examined the usefulness of the Alzheimer's Disease Assessment Scale-Late Version (ADAS-L) for assessing cognitive and behavioral impairment in geriatric schizophrenic patients. Subjects were 339 geriatric schizophrenic inpatients. Discriminant function analyses compared the Mini-Mental State Examination (MMSE) with the ADAS-L as independent variables predicting the level of impairment on the criterion measure, the Clinical Dementia Rating. The ADAS-L surpassed the MMSE at correctly distinguishing severe to profound impairment; the MMSE was superior for identifying absent or questionable impairment. Findings provide evidence for the concurrent validity of the ADAS-L as an instrument for measuring impairment in geriatric schizophrenic inpatients.

Original languageEnglish
Pages (from-to)76-81
Number of pages6
JournalJournal of Neuropsychiatry and Clinical Neurosciences
Volume7
Issue number1
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Dive into the research topics of 'Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatients'. Together they form a unique fingerprint.

Cite this